etiroxate has been researched along with Hyperlipoproteinemia Type II in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kalinová, M; Sobotka, L; Zadák, Z | 1 |
Schwandt, P; Weisweiler, P | 1 |
Banz, H; Gall, FP | 2 |
2 trial(s) available for etiroxate and Hyperlipoproteinemia Type II
Article | Year |
---|---|
[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
Topics: Anticholesteremic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperlipoproteinemia Type II; Male; Thyroxine | 1980 |
[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyperlipoproteinemia Type II; Male; Thyroxine; Triglycerides | 1979 |
2 other study(ies) available for etiroxate and Hyperlipoproteinemia Type II
Article | Year |
---|---|
[Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
Topics: Adult; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Thyroxine | 1982 |
Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
Topics: Adult; Apolipoproteins; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Thyroxine; Triglycerides | 1981 |